Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study

J Geriatr Oncol. 2019 Nov;10(6):990-993. doi: 10.1016/j.jgo.2019.05.003. Epub 2019 May 13.
No abstract available

Keywords: Aged; Eribulin; Metastatic breast cancer; Safety.

Publication types

  • Letter
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Breast Neoplasms / drug therapy*
  • Feasibility Studies
  • Female
  • Furans / administration & dosage*
  • Furans / adverse effects
  • Humans
  • Ketones / administration & dosage*
  • Ketones / adverse effects
  • Retrospective Studies

Substances

  • Antineoplastic Agents
  • Furans
  • Ketones
  • eribulin